Inocula | Animal ID | ALT | AST | GGT | Tb | **Liver injury | HEV RNA detection | ***anti-HEV | Clinical interpretation**** | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(IU/dL) (#maximum value obtained) | (Score) | (dpi*) | (EIA reactivity) | ||||||||||
Serum | Saliva | ||||||||||||
Serum | Faeces | IgM | IgG | IgA | IgA | ||||||||
Br-swine | X15 | 73 | 295 | 315 | 0.8 | 2 | --- | 14 - 21 | + | + | + | nt | Subclinical hepatitis E |
Q11 | 24 | 31 | 64 | 0.7 | 1 | 14 | 7 - 21 | + | + | + | - | Subclinical hepatitis E without biochemical disorders | |
I3 | 40 | 54 | 224 | 0.8 | 2 | 39 - 53 | 21 - 53 | - | - | - | + | Subclinical hepatitis E | |
D-swine | 01 | 40 | 119 | 237 | 0.8 | 1 | 14 | 5 - 18 | + | + | + | - | Subclinical hepatitis E |
G3 | 32 | 42 | 138 | 0.8 | 1 | 7 - 14 | 7 - 18 | + | + | + | +/- | Subclinical hepatitis E without biochemical disorders | |
F3 | 99 | 302 | 238 | 0.7 | 1 | --- | --- | + | + | + | + | Biochemical and histological hepatitis E | |
Br-human | J3 | 57/46 | 50 | 293 | 0.8 | 1 | --- | --- | - | + | - | - | Biochemical and histological hepatitis E |
Ar-human | R7 | 21 | 213 | 188 | 0.8 | 0 | --- | 14 - 27 | + | + | + | nt | Subclinical hepatitis E |
Control | I2 | 21 | 43 | 92 | 0.8 | 0 | --- | --- | - | - | - | nt | Uninfected |
Q12 | 21 | 116 | 103 | 0.7 | 0 | --- | --- | - | - | - | - | Uninfected |